Pharmaceutical Technology Europe
Orally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.
Raviraj Pillai
Advertisement
Raviraj Pillai is Vice President, Integrated Product Development, at Dr Reddy's Laboratories Ltd (India). [email protected]
Articles by Raviraj Pillai
Pharmaceutical Technology Europe
Rapid advances in drug discovery have led to the identification of a number of compounds with good therapeutic potential.
Advertisement
Latest Updated Articles
Developing nanoparticle formulations or poorly soluble drugsNovember 1st 2008
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5